Abhay Joshi, Ph.D., M.B.A.
Chief Operating Officer, President of R&D and Product Operations
Dr. Abhay Joshi joined Revance in December 2015. From 2007 to 2015, he served as the President and Chief Executive Officer of Alvine Pharmaceuticals, a privately-held clinical stage company focused on the development of biologics targeting autoimmune and inflammatory diseases. He previously served as Executive Vice President and Chief Technical Officer at CoTherix, Inc., which was acquired by Actelion Ltd. in 2007. Prior to CoTherix, Dr. Joshi was Vice President of Global Technical Operations, Specialty Pharmaceuticals at Allergan, Inc., where he was responsible for the company’s global biologics manufacturing operations for BOTOX® and its Latin America and Asia Pacific pharmaceutical operations. Dr. Joshi serves on the Boards of Alvine Pharmaceuticals and Genyous Biomed International. He received his B.Tech in Chemical Engineering from the Indian Institute of Technology (IIT), New Delhi, and holds both an M.S.E. and Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, along with an M.B.A. from the University of California, Irvine.